Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Single-arm Study to Assess the Safety and Performance of the Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk

NCT04829929 is registered in ClinicalTrials.gov with Eclipse Medical Ltd. as lead sponsor.

NCT NCT04829929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04829929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Single-arm Study to Assess the Safety and Performance of the Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk
Lead sponsor
Eclipse Medical Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 17, 2020
Completion date
January 7, 2027
Enrollment
200 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

non-valvular atrial fibrillation